Husain Yar Khan

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Epstein Barr Virus

Endoplasmic Reticulum Stress

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

bioRxiv : the preprint server for biology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Mohammed H Uddin, Sahar F Bannoura, Yousef Mzannar, Ibrahim Hanna Azar, Eliza Wright Beal, Miguel Tobon, Steve H Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony Frank Shields, Mohammad Najeeb Al-Hallak, Asfar S Azmi
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. Molecular cancer therapeutics (2023)
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, Mohammed H Uddin, Hyejeong Jang, Eliza Wright Beal, Amalraj Thangasamy, Seongho Kim, Kay-Uwe Wagner, Ramzi M Mohammad, Mohammad Najeeb Al-Hallak, Boris C Pasche, Asfar S Azmi
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis. bioRxiv : the preprint server for biology (2023)
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Mohammed H Uddin, Sahar Bannoura, Yousef Mzannar, Ibrahim Azar, Eliza Beal, Miguel Tobon, Steve Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony F Shields, Mohammed Najeeb Al-Hallak, Asfar S Azmi
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. bioRxiv : the preprint server for biology (2023)
Husain Yar Khan, Mohammed H Uddin, Suresh Kumar Balasubramanian, Noor Sulaiman, Marium Iqbal, Mahmoud Chaker, Amro Aboukameel, Yiwei Li, William Senapedis, Erkan Baloglu, Ramzi M Mohammad, Jeffrey Zonder, Asfar S Azmi
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma. Cancers 14 (1) (2021)
Erlene K Seymour, Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel, Radhakrishanan Ramchandren, Christiane Houde, Golbon Sterbis, Jay Yang, Divaya Bhutani, Silvana Pregja, Kathy Reichel, Amy Huddlestun, Colleen Neveux, Kelly Corona, Yosef Landesman, Jatin Shah, Michael Kauffman, Sharon Shacham, Ramzi M Mohammad, Asfar S Azmi, Jeffrey A Zonder
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Mohammed H Uddin, Yiwei Li, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Rachel E Sexton, Shriya Reddy, Yosef Landesman, Trinayan Kashyap, Asfar S Azmi, Elisabeth I Heath
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells. International journal of molecular sciences 22 (13) (2021)
Asfar S Azmi, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Jasper Edgar Neggers, Dirk Daelemans, Amit Mahipal, Gregory Dyson, Mandana Kamgar, Mohammad Najeeb Al-Hallak, Anteneh A Tesfaye, Steve H Kim, Vinod Shidham, Ramzi M Mohammad, Philip A Philip
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)